Results from a prospective, multicenter study evaluated the Recana thrombectomy catheter system (InterVene, Inc.) for the ...
Early 30-day results from a prospective, real-world registry of the Abre venous self-expanding stent system (Medtronic) showed ...
Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...
Thrombolex, Inc., announced interim results from the first 150 patients enrolled in its RAPID-PE postmarket study, a ...
Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...
BD (Becton, Dickinson and Company) announced 9-month results from the iliac cohort of the AGILITY investigational device ...
Reva Medical, LLC announced the presentation of results from a subgroup analysis of the MOTIV BTK pivotal trial for the ...
Johnson & Johnson MedTech announced 24-month results from the DISRUPT PAD BTK II postmarket study assessing the continued sa ...
Frank J. Veith, MD, Chairman of the VEITHsymposium, announced that Gustavo S. Oderich, MD, will be assuming the role of the org ...
B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that ...
AngioDynamics, Inc. announced the appointment of Eric Honroth as President, Chief Executive Officer, and a member of the company ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results